JPWO2022093736A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022093736A5 JPWO2022093736A5 JP2023535666A JP2023535666A JPWO2022093736A5 JP WO2022093736 A5 JPWO2022093736 A5 JP WO2022093736A5 JP 2023535666 A JP2023535666 A JP 2023535666A JP 2023535666 A JP2023535666 A JP 2023535666A JP WO2022093736 A5 JPWO2022093736 A5 JP WO2022093736A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- dnaj
- aav
- tau
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105472P | 2020-10-26 | 2020-10-26 | |
| US63/105,472 | 2020-10-26 | ||
| PCT/US2021/056539 WO2022093736A1 (en) | 2020-10-26 | 2021-10-26 | Compositions and methods for the treatment of alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023548632A JP2023548632A (ja) | 2023-11-17 |
| JPWO2022093736A5 true JPWO2022093736A5 (https=) | 2024-10-30 |
| JP2023548632A5 JP2023548632A5 (https=) | 2024-10-30 |
Family
ID=78676670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535666A Pending JP2023548632A (ja) | 2020-10-26 | 2021-10-26 | アルツハイマー病の処置のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240025954A1 (https=) |
| EP (1) | EP4232462A1 (https=) |
| JP (1) | JP2023548632A (https=) |
| CN (1) | CN117098771A (https=) |
| AU (1) | AU2021367952A1 (https=) |
| CA (1) | CA3199433A1 (https=) |
| TW (1) | TW202233655A (https=) |
| WO (1) | WO2022093736A1 (https=) |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8918616D0 (en) | 1989-08-15 | 1989-09-27 | Univ Glasgow | Herpes simplex virus type 1 mutant |
| US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| AU8605598A (en) | 1997-07-31 | 1999-02-22 | University Of Pittsburgh | Targeted hsv vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| NZ522840A (en) | 2000-06-01 | 2004-12-24 | Univ North Carolina | A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together |
| JP2004502781A (ja) | 2000-07-07 | 2004-01-29 | パナシア ファーマシューティカルズ インコーポレーテッド | 神経組織の損傷を予防するため、およびα−シヌクレイン疾患を処置するための方法 |
| EP1828390B1 (en) | 2004-12-15 | 2012-06-13 | The University Of North Carolina At Chapel Hill | Chimeric vectors |
| EP2396343B1 (en) | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| ES2683695T3 (es) | 2010-01-12 | 2018-09-27 | The University Of North Carolina At Chapel Hill | Repeticiones terminales invertidas restrictivas para vectores virales |
| CA2788682C (en) | 2010-02-05 | 2019-03-05 | The University Of North Carolina At Chapel Hill | Compositions and methods for enhanced parvovirus transduction |
| WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| PT2935326T (pt) * | 2012-12-21 | 2020-09-14 | Biogen Ma Inc | Anticorpos anti-tau humanos |
| US12162929B2 (en) | 2018-02-19 | 2024-12-10 | New York University | Alpha-synuclein single domain antibodies |
| GB201902392D0 (en) * | 2019-02-21 | 2019-04-10 | Cambridge Entpr Ltd | Modular binding proteins |
| EP4132955A2 (en) * | 2020-04-10 | 2023-02-15 | SOLA Biosciences LLC | Compositions and methods for the treatment of protein aggregation disorders |
| BR112022021604A2 (pt) * | 2020-04-28 | 2022-12-06 | Sola Biosciences Llc | Composições e métodos para tratamento de proteinopatias associadas à tdp-43 |
-
2021
- 2021-10-26 US US18/033,454 patent/US20240025954A1/en active Pending
- 2021-10-26 CA CA3199433A patent/CA3199433A1/en active Pending
- 2021-10-26 TW TW110139655A patent/TW202233655A/zh unknown
- 2021-10-26 WO PCT/US2021/056539 patent/WO2022093736A1/en not_active Ceased
- 2021-10-26 CN CN202180087609.5A patent/CN117098771A/zh active Pending
- 2021-10-26 AU AU2021367952A patent/AU2021367952A1/en active Pending
- 2021-10-26 JP JP2023535666A patent/JP2023548632A/ja active Pending
- 2021-10-26 EP EP21810497.4A patent/EP4232462A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020522269A5 (https=) | ||
| JP2020505936A5 (https=) | ||
| JPWO2021113270A5 (https=) | ||
| JP6042825B2 (ja) | 改変された形質導入プロファイルを有するウイルスベクターならびにその製造および使用の方法 | |
| ES2230569T3 (es) | Funciones accesorias para uso en la produccion de viriones aav recombinantes. | |
| JP2021106619A5 (https=) | ||
| JP2018522529A5 (https=) | ||
| JP2018148927A5 (https=) | ||
| JP2021512649A5 (https=) | ||
| JP2007507223A5 (https=) | ||
| CN112041442A (zh) | 用于逃避抗体的病毒载体的方法和组合物 | |
| JP2017536116A5 (https=) | ||
| JP2009526067A5 (https=) | ||
| JP2018531609A5 (https=) | ||
| TW201629225A (zh) | 第九因子基因療法 | |
| JP7558535B2 (ja) | アルデヒドデヒドロゲナーゼ欠損症の治療のための遺伝子治療 | |
| Bello et al. | Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues | |
| JP2021523702A5 (https=) | ||
| JP2017529395A5 (https=) | ||
| JPWO2020069461A5 (https=) | ||
| JP2021534755A5 (https=) | ||
| BR112021005788A2 (pt) | Métodos e composições para aumentar a expressão de proteínas e/ou tratar um distúrbio de haploinsuficiência | |
| JP2020519294A5 (https=) | ||
| JP2021534794A5 (https=) | ||
| JPWO2022093736A5 (https=) |